Healthleap, a South African startup developing an AI platform that analyzes patient records to identify hospital patients at risk of undiagnosed illnesses, has raised $38 million in seed and Series A funding. The financing includes an $8 million seed round co-led by Sequoia Capital and First Round Capital, and a $30 million Series A led by Hummingbird Ventures, TechCrunch reported.
Founded in 2022 by siblings Jemima and Josiah Meyer, Healthleap initially created a clinical nutrition tool before pivoting to a broader platform that detects conditions like malnutrition and delirium often missed early in hospital patients. CEO Josiah Meyer explained that the AI extracts critical clinical concepts from both structured data and clinicians’ written notes, enabling scalable identification of patient risks. The platform is currently deployed in over 50 hospitals.
Healthleap’s technology addresses a significant gap in hospital care by flagging patients who may need closer attention for conditions that are not always detected promptly. This approach aligns with growing interest in AI applications in healthcare, where early intervention can improve outcomes and reduce costs. The funding round places Healthleap alongside other startups leveraging AI to enhance clinical decision-making and patient monitoring.
The $38 million funding will support Healthleap’s expansion and further development of its AI capabilities. The company did not disclose its valuation. Deployment across more hospitals is expected as the startup scales its platform to improve patient care through earlier detection of critical conditions.